Showing 2114 companies
Company Headquarters: Laval, Canada Founded: 1959 Workforce: ~21,700 Company Working: Bausch Health Companies Inc. (Bausch Health) is one of the leading multinational specialty pharmaceutical company. The company develops, manufactures, and markets products for therapeutic areas such as gastroenterology (GI), dermatology, and eye health. It provides a broad range of over-the-counter (OTC) products, generic and branded generic pharmaceuticals, medical device, and branded pharmaceuticals. It was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. effective from July 2018. Bausch Health Companies Inc. provides its dermatology products through its segment named Ortho Dermatologics.
Company Headquarters: Lewisville, Texas, US Founded: 1980 Workforce: ~954 Company Working: Orthofix Holdings, Inc. (Orthofix) is a company that manufactures medical devices. It focuses on musculoskeletal therapies and products. The company operates through four operating segments, namely, bone growth therapies, spinal implants, biologics, and Orthofix extremities. The products manufactured and marketed by the company include devices that enhance bone fusion (bone growth therapies segment), implants used in spine surgeries (spinal implants segment), regenerative products and different forms of tissues to treat orthopedic and spinal conditions (biologics), and products to treat orthopedic conditions not related to the spine (Orthofix extremities segment). Orthofix Holdings, Inc. distributes its products via sales distributors and representatives in over 70 countries.
Company Headquarters: France Founded: 2008 Workforce: ~200 Company Working: Global Bioenergies is a technology-driven company that develops processes to convert renewable resources into hydrocarbons through fermentation. The company primarily focuses on the conversion of sugar, crops, and agricultural and forestry waste into isobutene. It has four subsidiaries, namely, Global Bioenergies GmbH, Syngip, IBN-One SA, and IBN-Two. Global Bioenergies GmbH, based in Germany, builds and operates an industrial-scale demonstrator at its refinery and focuses on specialized engineering services in gas fermentation. Syngip was founded in 2014 and has developed a process for the conversion of gaseous carbon sources into various valuable chemical compounds such as light olefins and petrochemical molecules, including isobutene. IBN-One SA was a wholly owned subsidiary of Global Bioenergies but was converted into a 50/50 joint venture with Cristal Union in May 2015. The company has obtained a license from Global Bioenergies to operate an isobutene process plant producing 50,000 tonnes annually. IBN-Two is based in Germany and has been established as a vehicle for bringing together German industry players to raise financing for building and operating the first bio-sourced isobutene production facility in the country.
Unlock Verified Contacts
Access verified employee contacts
Decision-maker information to support your sales, lead generation, and business development. 5 users, 5,500 credits a month with rollover, and one credit per contact email.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence